Notice Number: NOT-DA-19-035
Key Dates
Release Date: July 17, 2019Estimated Publication Date of Funding Opportunity Announcement: September 08, 2019
First Estimated Application Due Date: October 05, 2019
Earliest Estimated Award Date: February 01, 2020
Earliest Estimated Start Date: February 01, 2020
Related Announcements
PAR-18-062
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The National Institute on Drug Abuse (NIDA) intends to reissue PAR-18-062 "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)" to solicit applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription and other substances) and related disorders, prevention of substance use and HIV, and health service utilization.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The FOA is expected to be published in September 2019 with an expected application due date in October 2019.
This FOA will utilize the R01 activity code.
Details of the planned FOA are provided below.
Research Initiative Details
This Notice encourages investigators to submit innovative analyses of extant data, including new aims that are being addressed with existing data, new or advanced methods of analyses, or novel combination and integration of datasets to allow the exploration of new questions.
Strongly encouraged is the application of innovative methods or techniques from other disciplines that are novel to substance use and disorder research, such as utilization of systems science methodologies (e.g., agent based modeling, system dynamics modeling, network analysis) or geographic information systems (GIS). Use of multiple sources of data towards predicting substance use behaviors and solutions is also encouraged.
Grants under this announcement are not intended as a means to carry out currently ongoing data analysis, for the maintenance and distribution of data sets, or to analyze banked biospecimens for which data are not already available. Proposed research should be distinct from the aims and methods of the primary research under which the data were collected. For example, datasets collected for other purposes might be reanalyzed to address issues of health disparities and subgroup differences in the trajectories of substance use, prevention outcomes, and treatment utilization and outcomes including morbidity and mortality. Research using extant data that analyzes effects or outcomes that were not previously examined in the original scope of research is a priority for this announcement.
Funding Information
Estimated Total Funding TBD
Expected Number of Awards TBD
Estimated Award Ceiling TBD
Primary CFDA Numbers 93.279
Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Non-domestic (non-U.S.) Entity (Foreign Organization)
Regional Organization
Eligible Agencies of the Federal Government
Applications are not being solicited at this time.
Inquiries
Please direct all inquiries to:
Marsha F. Lopez, Ph.D., M.H.S
National Institute on Drug Abuse (NIDA)
301-443-6504
[email protected]
and Human Services (HHS)
